Screener
First Tracks Biotherapeutics Inc TRAX Operating Cash Flow
Operating Cash Flow at other companies
Where this comes from
Reported directly by First Tracks Biotherapeutics Inc in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: First Tracks Biotherapeutics Inc’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224190
| (in thousands) | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Prepaid expenses and other assets | 2,157 | (443) |
| Accounts payable and other liabilities | 4,146 | (3,590) |
| Operating lease liabilities | — | (462) |
| Net cash used in operating activities | (32,561) | (45,006) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Purchase of investments | — | (122,547) |
| Sales and maturities of investments | 35,000 | 137,429 |
| Purchases of property and equipment | (17) | (35) |
Item 1. Combined Financial Statements.
FAQ
- What is First Tracks Biotherapeutics Inc's operating cash flow?
- First Tracks Biotherapeutics Inc (TRAX) reported operating cash flow of -$32.56M in Q1 2026.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about First Tracks Biotherapeutics Inc's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude